Executive Summary
This matter was transferred from the Intellectual Property Appellate Board (IPAB) to the Calcutta High Court following the enactment of the Tribunals Reform Act, 2021. The court directed the Commercial Appellate Division to issue notices and file a report before listing the case in March 2023.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court. Understanding the court's reasoning in Vicuron Pharmaceuticals, Inc vs Controller General of Patents and Designs and Anr is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Mankind Pharma LimitedvsS.A Medline Private Limited
Mankind Pharma Limited and S.A Medline Private Limited reached a joint settlement in the Delhi High Court regarding a trademark dispute. As part of the compromise, the defendant agreed to withdraw its contested trademark registration (No. 5328362) within seven days. The court accepted the terms, decreeing the suit against the defendant and allowing for a refund of court fees.
Mohan KumarvsM/S. Narendra Products
The Delhi High Court addressed a preliminary issue regarding territorial jurisdiction in a trademark infringement suit filed by Mohan Kumar against M/S. Narendra Products. The plaintiff sought an injunction against the use of the similar mark 'SHANKER' for Pan Masala (Gutka). The court ruled that it possessed jurisdiction, noting that the defendant had applied for registration and advertised the mark in Delhi, thereby establishing a sufficient connection to the territorial limits.
Classic Legends Private Limited / Mr. Boman R. IranivsThe Official Liquidator of M/S Ideal Jawa Private Limited
The Karnataka High Court allowed appeals filed by Classic Legends Private Limited (and Mr. Boman R. Irani) against an earlier ruling concerning the trade marks of Ideal Jawa. The court ruled that since the company had not used or renewed its registered trade marks for decades, no goodwill would subsist, and the rights had dissipated due to non-use. This decision significantly impacts the value and enforceability of the brand in liquidation proceedings.
Akums Drugs An Pharmaceuticals LimitedvsMedivinc Healthcare Pvt Ltd & Anr.
The Delhi High Court addressed several interlocutory applications in the trademark infringement suit filed by Akums Drugs against Medivinc Healthcare. The court granted exemptions for various procedural requirements, including pre-institution mediation and advance service to defendants. Crucially, the court allowed the plaintiffs' application for an ex parte ad-interim injunction, directing the appointment of Local Commissioners to secure evidence and prevent further infringement.
FMC Corporation & Ors.vsNatco Pharma Limited
The plaintiffs, FMC Corporation & Ors., filed an application seeking an interim injunction against Natco Pharma Limited, alleging infringement of their patented Compound of Formula 3 (IN'645). The suit was a quia timet action concerning the product 'Cyantraniliprole 10.26% OD'. Despite the defendant having already launched the product, the Delhi High Court dismissed the application for an interim injunction. The court found that the plaintiffs failed to establish a prima facie case and noted that damages could be compensable at trial.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.